Ondansetron HCL 8 MG tablet 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FAKSE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $23,939
Award facts
- Contract value 100% obligated
- $23,939.07 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to Amerisourcebergen Drug Corp (parent company Cencora, Inc.) on February 2, 2026, for the supply of Ondansetron HCL 8 mg tablets in 30-count packages. This firm fixed-price delivery order, valued at $23,939.07, represents a non-competitive award and is scheduled for completion by February 3, 2026. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This award is a child task order issued under Amerisourcebergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
Amerisourcebergen Drug Corp functions as a critical pharmaceutical distributor within the federal medical supply chain, supplying prescription medications, generic drugs, medical devices, and specialized healthcare commodities to support military treatment facilities and other government healthcare systems. The company's extensive portfolio with the Defense Logistics Agency demonstrates its capability to fulfill diverse pharmaceutical requirements across multiple therapeutic domains on a competitive basis. This delivery order for Ondansetron, an antiemetic medication commonly used in military and federal healthcare settings, exemplifies the routine pharmaceutical procurement activities executed under the company's prime vendor framework with the DLA.
Quick answers
Who was awarded contract SPE2DR26FAKSE?
SPE2DR26FAKSE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on February 2, 2026.
How much is contract SPE2DR26FAKSE worth?
The government has obligated $23,939 on SPE2DR26FAKSE.
Is contract SPE2DR26FAKSE an order under another contract?
Yes. SPE2DR26FAKSE is a delivery order under SPE2DR25D1201, an indefinite delivery contract.
Was contract SPE2DR26FAKSE competed?
The extent of competition for SPE2DR26FAKSE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award